Abstract:Immunotherapy has revolutionized the treatment of cancer in recent years and achieved overall success and long-term clinical benefit in patients with a wide variety of cancer types. However, there is still a large proportion of patients exhibiting limited or no responses to immunotherapeutic strategy, some of which were even observed with hyperprogressive disease. One major obstacle restricting the efficacy is that tumor-reactive CD8+ T cells, which are central for tumor control, undergo exhaustion, and lose their ability to eliminate cancer cells after infiltrating into the strongly immunosuppressive tumor microenvironment. Thus, as a potential therapeutic rationale in the development of cancer immunotherapy, targeting or reinvigorating exhausted CD8+ T cells has been attracting much interest. Hitherto, both intrinsic and extrinsic mechanisms that govern CD8+ T-cell exhaustion have been explored. Specifically, the transcriptional and epigenetic landscapes have been depicted utilizing single-cell RNA sequencing or mass cytometry (CyTOF). In addition, cellular metabolism dictating the tumor-infiltrating CD8+ T-cell fate is currently under investigation. A series of clinical trials are being carried out to further establish the current strategies targeting CD8+ T-cell exhaustion. Taken together, despite the proven benefit of immunotherapy in cancer patients, additional efforts are still needed to fully circumvent limitations of exhausted T cells in the treatment. In this review, we will focus on the current cellular and molecular understanding of metabolic changes, epigenetic remodeling, and transcriptional regulation in CD8+ T-cell exhaustion and describe hypothetical treatment approaches based on immunotherapy aiming at reinvigorating exhausted CD8+ T cells.

The Interplay Between Epigenetic Regulation and CD8+ T Cell Differentiation/Exhaustion for T Cell Immunotherapy

Fundamentals to therapeutics: Epigenetic modulation of CD8+ T Cell exhaustion in the tumor microenvironment

Reinvigorating Exhausted CD8+ Cytotoxic T Lymphocytes in the Tumor Microenvironment and Current Strategies in Cancer Immunotherapy

Epigenetics behind CD8 + T cell activation and exhaustion

Targeting the epigenome to reinvigorate T cells for cancer immunotherapy.

Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy

Strategies to reinvigorate exhausted CD8+ T cells in tumor microenvironment

CD8+ T cell exhaustion and its regulatory mechanisms in the tumor microenvironment: key to the success of immunotherapy

Clinical implications of T cell exhaustion for cancer immunotherapy

CD8<SUP>+</SUP> T cell exhaustion in anti-tumour immunity: The new insights for cancer immunotherapy

The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer

Epigenetic reprogramming of T cells: unlocking new avenues for cancer immunotherapy

T cell exhaustion in human cancers

Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets

Immunological hide-and-seek: epigenetically reprogrammed cancer cells and the dynamics of CD8+ T cells

Decoding and overcoming T cell exhaustion: Epigenetic and transcriptional dynamics in CAR-T cells against solid tumors

Exhausted T cells and epigenetic status

T-cell exhaustion and stemness in antitumor immunity: Characteristics, mechanisms, and implications

T Cell Dysfunction and Exhaustion in Cancer

Mechanisms of T cell exhaustion guiding next-generation immunotherapy

The Interplay between T Cells and Cancer: The Basis of Immunotherapy